Long acting follicle stimulating hormone versus daily follicle stimulating hormone for women undergoing assisted reproduction

We conducted a systematic review of the use of long acting versus daily follicle-stimulating hormone for women undergoing assisted reproduction.

Like Comment

Authors

Annefloor W. Pouwer, M.Sc., Cynthia Farquhar, M.P.H., Jan A.M. Kremer, Ph.D., Jane Marjoribanks, M.P.H.

Volume 105, Issue 6, Pages 1454-1456

Abstract

Follicle-stimulating hormone (FSH) given as a weekly injection in a medium dose is as safe and effective as a daily FSH injection for women undergoing assisted reproduction.

Read the full text at: http://fertstertforum.com/pouwera-long-acting-versus-daily-fsh-art/


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.